Neko Health, a Swedish health-tech company co-founded by and Hjalmar Nilsonne and Spotify’s Daniel Ek, has launched an advanced body scanning technology that uses artificial intelligence (AI) with medical imaging to provide health assessments, aiming to detect potential health issues on the skin before they become serious.
Their full-body scanner conducts non-invasive health check-ups in minutes using high-resolution skin images, measures biomarkers, while performing cardiovascular assessments. The system uses over 70 sensors to collect 50 million data points, analysing everything from skin anomalies to heart and vascular conditions. AI processes this data in real time, providing detailed reports that help individuals and doctors make informed health decisions.
Neko does not use MRI-based scans but focuses on non-invasive scanning technology, which includes:
- 3D Body Scanning – Captures skin conditions and anomalies.
- Infrared Light & Sensors – Measures skin and vascular health.
- AI-powered Analysis – Detects early signs of potential health risks.
- Full-body Ultrasound & ECG (depending on the package) – Monitors cardiovascular health.
This technology focuses on preventive rather than traditional healthcare systems that often address illnesses only after symptoms appear. This approach could reduce the burden on healthcare providers and lower long-term treatment costs.
Currently, Neko operates clinics in Stockholm and London, with plans to expand into other European countries and the United States. The service costs approximately €250–€300 per scan, making it more accessible than traditional private medical check-ups.
Neko has attracted significant investment to advance its preventive healthcare services. In July 2023, the company secured €60 million in a Series A funding round led by Lakestar, with participation from Atomico and General Catalyst. In January 2025, the company raised $260 million in a Series B round announced in January 2025 led by Lightspeed Venture Partners, with contributions from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico. This funding gave them a valuation to approximately $1.7 billion that supports their expansion into the U.S. and other international markets.
| Feature | Neko Health | Prenuvo (MRI-based) | Ezra (MRI-based) |
| Technology Used | 3D body scanning, infrared light, ultrasound, ECG, AI analysis | Full-body MRI | Full-body MRI |
| Radiation Exposure | None (non-invasive) | None (MRI is radiation-free) | None (MRI is radiation-free) |
| Scanning Time | 10-15 minutes | ~60 minutes | ~60 minutes |
| Detection Focus | Skin, cardiovascular, vascular health, potential risk factors | Tumors, organ health, internal diseases | Tumors, organ health, internal diseases |
| Cost | Lower (€250-€300 per scan) | Higher ($999+ per scan) | Higher ($1350+ per scan) |
| Availability | Limited (Stockholm, London) | USA, Canada (expanding) | USA (expanding) |
| Main Strengths | Quick, affordable, preventive-focused | Highly detailed internal imaging | Highly detailed internal imaging |
| Main Weaknesses | No deep internal scans, limited locations | Expensive, time-consuming | Expensive, requires contrast agents for some scans |
